MFA
BIIB icon

Mayflower Financial Advisors’s Biogen BIIB Stock Holding History

Mayflower Financial Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-979
Closed -$206K – 338
2022
Q1 		$206K Buy
+979
New +$213K 0.03% 328
2021
Q1 		– Sell
-1,347
Closed -$330K – 306
2020
Q4 		$330K Buy
+1,347
New +$347K 0.06% 196

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Mayflower Financial Advisors's BIIB Position: Q2 2022 in Review

Mayflower Financial Advisors sold out of Biogen (BIIB) in Q2 2022, closing a stake of 979 shares — an estimated $206K sold.

Mayflower Financial Advisors first reported a position in BIIB in Q4 2020 and held it in 2 quarters. The position peaked at $330K in Q4 2020. 928 funds tracked by Wall St. Rank hold BIIB as of Q2 2022.

  • Mayflower Financial Advisors reported no remaining Biogen position as of Q2 2022 after selling out during the quarter.
  • Mayflower Financial Advisors sold 979 Biogen shares in Q2 2022, an estimated $206K.
  • Mayflower Financial Advisors first reported a position in Biogen in Q4 2020 and held it in 2 quarters.
  • Mayflower Financial Advisors's Biogen position peaked at $330K in Q4 2020.
  • 928 funds tracked by Wall St. Rank held Biogen as of Q2 2022.

Based on Mayflower Financial Advisors's 13F filing for Q2 2022, filed 15 Jul 2022.